Heart health in people with inflammatory bowel disease
Part of Brain & nervous system, Digestive system, Heart & circulation clinical trials.
This study looks at heart health in people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. It may help doctors understand and manage heart risks in IBD patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of ulcerative colitis or Crohn's disease.
- You must be 18 years old or older.
- You must be willing to follow the study plan and attend all required appointments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This study follows people who have a parent, sibling, or child with Crohn's disease or ulcerative colitis to help understand why some family members develop the condition. If you are 14 or older and do not already have IBD, you may be able to join.
This study looks at whether certain blood tests (called inflammatory biomarkers) can help measure how active your inflammatory bowel disease (Crohn's disease or ulcerative colitis) is. It may help doctors better track your condition and guide treatment, without needing invasive procedures.
This study looks at heart health in people with Crohn's disease or ulcerative colitis. It aims to understand the risk of heart problems over 2 years.
This study looks at how diet affects inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It may help understand if certain foods can improve symptoms.
This study uses a special type of ultrasound (called speckle tracking echocardiography) to check how well the heart works in people with inflammatory bowel disease. It may help doctors understand if the disease affects the heart, even when it isn't causing symptoms.
Hear when a new Cardiovascular Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.